These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7927731)

  • 1. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification.
    Weis JJ; Ma Y; Erdile LF
    Infect Immun; 1994 Oct; 62(10):4632-6. PubMed ID: 7927731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
    Ma Y; Weis JJ
    Infect Immun; 1993 Sep; 61(9):3843-53. PubMed ID: 8359905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant.
    Erdile LF; Guy B
    Vaccine; 1997 Jun; 15(9):988-96. PubMed ID: 9261945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.
    Ma Y; Seiler KP; Tai KF; Yang L; Woods M; Weis JJ
    Infect Immun; 1994 Sep; 62(9):3663-71. PubMed ID: 7520417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes.
    Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R
    Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro.
    Sellati TJ; Abrescia LD; Radolf JD; Furie MB
    Infect Immun; 1996 Aug; 64(8):3180-7. PubMed ID: 8757851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ; Huebner RC; Kasmiersky V; Barbour AG
    Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.
    Erdile LF; Brandt MA; Warakomski DJ; Westrack GJ; Sadziene A; Barbour AG; Mays JP
    Infect Immun; 1993 Jan; 61(1):81-90. PubMed ID: 8418068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
    Tai KF; Ma Y; Weis JJ
    Infect Immun; 1994 Feb; 62(2):520-8. PubMed ID: 8300210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens.
    de Souza MS; Fikrig E; Smith AL; Flavell RA; Barthold SW
    J Infect Dis; 1992 Mar; 165(3):471-8. PubMed ID: 1531672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.
    Giambartolomei GH; Dennis VA; Lasater BL; Philipp MT
    Infect Immun; 1999 Jan; 67(1):140-7. PubMed ID: 9864208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
    Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
    Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine IgG1 monoclonal antibody that binds specifically to outer surface protein A of Lyme disease spirochete Borrelia burgdorferi.
    Abolhassani M; Pavia CS; Dunn JJ; Chiao JW
    FEMS Microbiol Lett; 1993 May; 109(2-3):303-9. PubMed ID: 8339920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells.
    Comstock LE; Fikrig E; Shoberg RJ; Flavell RA; Thomas DD
    Infect Immun; 1993 Feb; 61(2):423-31. PubMed ID: 7678585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
    de Silva AM; Fish D; Burkot TR; Zhang Y; Fikrig E
    Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an immunologically important hypervariable domain of major outer surface protein A of Borrelia burgdorferi.
    McGrath BC; Dunn JJ; Gorgone G; Guttman D; Dykhuizen D; Luft BJ
    Infect Immun; 1995 Apr; 63(4):1356-61. PubMed ID: 7890394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.